Designing stability testing: choosing long term, intermediate and accelerated conditions, what a stability test chamber and stability test chambers must prove about themselves, and how a pharmaceutical stability protocol, accelerated stability testing and shelf life testing turn into a shelf life claim

Stability testing produces one number that matters, the shelf life, and it produces it slowly. Everything in the design exists to make that number defensible: the storage conditions, the time points, the analytical methods and the evidence that the chamber held what it claimed. This page covers the design and the two things that most often invalidate a study after it has run.

the conventional long term condition for a room temperature product
25 C / 60% RH
the conventional accelerated condition beside it
40 C / 75% RH
the good manufacturing practice regulation the study supports
Part 211

Figures in this panel are the conventional storage conditions a stability programme is designed around and the regulation the study supports, named from the guidance and regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a testing price index it has not measured.

Designing the study

  1. Choose the conditions from the climatic zone and the storage claim. The conventional long term condition for a room temperature product is twenty five degrees at sixty percent relative humidity, with an accelerated condition at forty degrees and seventy five percent. An intermediate condition is added where the accelerated data shows significant change. Refrigerated and frozen products have their own sets.
  2. Use a stability-indicating method, and prove it is one. The analytical method has to separate the product from its degradation products, which is demonstrated by forced degradation: acid, base, oxidation, heat and light, showing that the assay still measures the intact product. A method that cannot do this cannot support a shelf life.
  3. Fix the time points and the batches before starting. Long term studies conventionally test at three month intervals in the first year, six monthly in the second and annually after. Three primary batches is the usual expectation for a registration study. Adding a batch later does not retrofit the design.
  4. Test in the container you will actually sell. Stability is a property of the product in its container closure system, so a study in a laboratory bottle says nothing about a blister or a prefilled syringe. Orientation matters too where the product contacts the closure.
  5. Prove the chamber before you trust the study. A stability test chamber needs mapping, with distributed sensors, loaded, showing that every shelf held the condition. It also needs an alarm and a documented excursion procedure, because the question asked later is always what happened during the power cut.

Outsourcing it

A contract laboratory brings mapped chambers, a monitoring record and analytical capacity, and takes on the obligation to keep the samples in condition for years. Ask to see the mapping reports and the excursion log rather than the certificate.

Settle what happens to your samples if the provider ceases trading or you move. Long term stability samples stranded at a laboratory you no longer use is a problem with no good solution.

Photostability and the tests people forget

Light exposure testing is a separate study with its own conditions and its own control, and it is frequently remembered late. Where a product will sit under lighting, it is not optional.

Freeze-thaw and in-use stability, for a product that will be opened and used over days, are similarly forgotten and similarly expected. Map them onto the plan at the start.

Reading the data as it comes

Trend the results as the time points land rather than waiting for the end. A trend heading towards a specification limit at eighteen months is a manageable problem; discovering it at thirty six months is not.

Define significant change and out of specification handling in the protocol. Deciding what a result means after seeing it is the weakest position to be in during a review.

Common questions

What conditions does stability testing use?
Commonly twenty five degrees at sixty percent relative humidity for long term and forty degrees at seventy five percent for accelerated, for a room temperature product, with an intermediate condition added when accelerated data shows significant change. Refrigerated and frozen products use their own sets.
What makes a method stability-indicating?
Demonstrated separation of the product from its degradation products, shown by forced degradation under acid, base, oxidation, heat and light with mass balance. Without that evidence the assay may be measuring degradation products as product.
How much does the chamber matter?
Entirely. An unmapped chamber means you do not know what any sample experienced, and an excursion without a documented assessment leaves every subsequent time point open to challenge. Mapping and alarm handling are the study's foundation.
Can accelerated data alone support a shelf life?
It can support a provisional claim in some frameworks, and it is not a substitute for real time data. Extrapolating beyond what the guidance allows is the commonest way a shelf life claim is rejected.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/stability-testing/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices